UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000006513
Receipt No. R000007719
Scientific Title Phase 1/2 study of the combination of Bendamustine and Rituximab for treatment of elderly relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma.
Date of disclosure of the study information 2011/10/18
Last modified on 2011/10/10 15:34:26

No. Disposal Last modified on Item of update
1 Insert 2011/10/10 18:23:48


Contact us.